VECURONIUM BROMIDE

N/A

Manufactured by Eugia US LLC

3,750 FDA adverse event reports analyzed

Last updated: 2026-04-15

About VECURONIUM BROMIDE

VECURONIUM BROMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Eugia US LLC. The most commonly reported adverse reactions for VECURONIUM BROMIDE include RENAL FAILURE, HYPOTENSION, PAIN, CARDIAC ARREST, INJURY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for VECURONIUM BROMIDE.

Top Adverse Reactions

RENAL FAILURE132 reports
HYPOTENSION123 reports
PAIN121 reports
CARDIAC ARREST108 reports
INJURY104 reports
UNEVALUABLE EVENT101 reports
ANXIETY100 reports
RENAL IMPAIRMENT94 reports
BRADYCARDIA93 reports
FEAR93 reports
RENAL INJURY83 reports
DRUG INEFFECTIVE78 reports
EMOTIONAL DISTRESS77 reports
ANAPHYLACTIC REACTION76 reports
DRUG INTERACTION76 reports
MULTI ORGAN FAILURE75 reports
STRESS72 reports
TACHYCARDIA68 reports
DEATH64 reports
ANHEDONIA61 reports
BLOOD PRESSURE DECREASED56 reports
RHABDOMYOLYSIS54 reports
HYPERTHERMIA MALIGNANT51 reports
ANAPHYLACTIC SHOCK48 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED42 reports
POST PROCEDURAL COMPLICATION42 reports
VENTRICULAR FIBRILLATION41 reports
VENTRICULAR TACHYCARDIA41 reports
OXYGEN SATURATION DECREASED40 reports
RENAL FAILURE ACUTE40 reports
PYREXIA39 reports
ANAESTHETIC COMPLICATION38 reports
PROCEDURAL COMPLICATION36 reports
ARTERIOSPASM CORONARY34 reports
BRONCHOSPASM34 reports
RESPIRATORY FAILURE32 reports
CEREBROVASCULAR ACCIDENT31 reports
COGNITIVE DISORDER30 reports
HYPOXIA29 reports
METABOLIC ACIDOSIS29 reports
DEPRESSION28 reports
PULMONARY OEDEMA28 reports
ASPARTATE AMINOTRANSFERASE INCREASED27 reports
RESPIRATORY ARREST27 reports
SEPSIS27 reports
VENTRICULAR EXTRASYSTOLES27 reports
ASTHENIA26 reports
DYSPNOEA26 reports
MUSCULAR WEAKNESS26 reports
HYPERTENSION25 reports
NAUSEA25 reports
NEUROMUSCULAR BLOCK PROLONGED25 reports
DELAYED RECOVERY FROM ANAESTHESIA24 reports
CHILLS23 reports
ALANINE AMINOTRANSFERASE INCREASED22 reports
BLOOD PRESSURE INCREASED22 reports
HYPERKALAEMIA22 reports
MEDICATION ERROR22 reports
TOXICITY TO VARIOUS AGENTS22 reports
MYOCARDIAL INFARCTION21 reports
AGITATION20 reports
CONVULSION20 reports
ELECTROCARDIOGRAM ST SEGMENT ELEVATION20 reports
PARALYSIS20 reports
SEROTONIN SYNDROME20 reports
TORSADE DE POINTES20 reports
CARDIAC FAILURE19 reports
CONDITION AGGRAVATED19 reports
PNEUMONIA19 reports
SHOCK19 reports
URTICARIA19 reports
ACIDOSIS18 reports
BLOOD CREATININE INCREASED18 reports
CARDIO RESPIRATORY ARREST18 reports
LOSS OF CONSCIOUSNESS18 reports
RESPIRATORY ACIDOSIS18 reports
VOMITING18 reports
ANAEMIA17 reports
ATRIOVENTRICULAR BLOCK COMPLETE17 reports
HEPATIC FUNCTION ABNORMAL17 reports
DEEP VEIN THROMBOSIS16 reports
ELECTROCARDIOGRAM QT PROLONGED16 reports
ERYTHEMA16 reports
EXTRASYSTOLES16 reports
WEIGHT DECREASED16 reports
DRUG EXPOSURE DURING PREGNANCY15 reports
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION15 reports
HEART RATE DECREASED15 reports
HEART RATE INCREASED15 reports
OFF LABEL USE15 reports
SOMNOLENCE15 reports
ABDOMINAL DISTENSION14 reports
BACK PAIN14 reports
CARDIAC FAILURE CONGESTIVE14 reports
CYANOSIS14 reports
HAEMORRHAGE14 reports
MYOPATHY14 reports
TACHYPNOEA14 reports
VASOPLEGIA SYNDROME14 reports
CHROMATURIA13 reports

Report Outcomes

Out of 1,514 classified reports for VECURONIUM BROMIDE:

Serious 90.4%Non-Serious 9.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male661 (48.4%)
Female649 (47.5%)
Unknown57 (4.2%)

Reports by Age

Age 5933 reports
Age 6730 reports
Age 6029 reports
Age 6126 reports
Age 5525 reports
Age 7625 reports
Age 5023 reports
Age 6223 reports
Age 322 reports
Age 1322 reports
Age 4722 reports
Age 6822 reports
Age 7522 reports
Age 2221 reports
Age 6421 reports
Age 6621 reports
Age 2419 reports
Age 7019 reports
Age 7419 reports
Age 4018 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with VECURONIUM BROMIDE?

This profile reflects 3,750 FDA FAERS reports that mention VECURONIUM BROMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for VECURONIUM BROMIDE?

Frequently reported terms in FAERS include RENAL FAILURE, HYPOTENSION, PAIN, CARDIAC ARREST, INJURY, UNEVALUABLE EVENT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures VECURONIUM BROMIDE?

Labeling and FAERS entries often list Eugia US LLC in connection with VECURONIUM BROMIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.